Crossmark

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson’s disease

Crossref DOI link: https://doi.org/10.1186/s40478-021-01121-w

Published Online: 2021-02-12

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Smolders, Stefanie

Philtjens, Stéphanie

Crosiers, David

Sieben, Anne

Hens, Elisabeth

Heeman, Bavo

Van Mossevelde, Sara

Pals, Philippe

Asselbergh, Bob

Dos Santos Dias, Roberto

Vermeiren, Yannick

Vandenberghe, Rik

Engelborghs, Sebastiaan

De Deyn, Peter Paul

Martin, Jean-Jacques

Cras, Patrick

Annaert, Wim

Van Broeckhoven, Christine http://orcid.org/0000-0003-0183-7665
Funding

Funding for this research was provided by:

Flemisch Goverment Initiated Methusalem Ecellence Program

SAO-FRA Research Foundation for Alzheimer’s disease

Belgian Science Policy Office Interuniversity Attraction Poles program

Flanders Impulse Program on Networks for Dementia Research and the Methusalem Excellence Program

Rsearch Foundation Flanders

University of Antwerp Research Fund

KU Leuven research council

Fund Bonmariage de Bouyalski by the King Baudouin Foundation
License Information

Text and Data Mining valid from 2021-02-12

Version of Record valid from 2021-02-12
More Information

Article History

Received: 21 October 2020

Accepted: 14 January 2021

First Online: 12 February 2021

Ethics approval and consent to participate

: The ethic committee of the University Hospital of Antwerp and University of Antwerp approved the informed consent form and the clinical, pathological and genetic protocoils used in this studie. All participants, patients and controls, signed an informed consent document.

: Not applicable.

: None of the authors reported personal competing financial interests.

Document is current

Any future updates will be listed below